ContraVir Pharmaceuticals Announces New Data Presented at the 2018 International Liver Congress™
CONTRAVIR PHARMACEUTICALS INC (CTRV)
US:NASDAQ Investor Relations:
ir.contravir.com/investor-relations
Company Research
Source: GlobeNewswire
EDISON, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of hepatitis B virus (HBV) announced today, the presentation of new data on TXL™ and CRV431 at the 53rd Annual International Liver Congress™ 2018 (EASL) in Paris, France. “Each of these posters highlights our increasing knowledge of how TXL™ and CRV431 may best be positioned for combination therapy in the treatment of HBV,” commented Robert Foster, Chief Scientific Officer of ContraVir. “We are particularly thankful to our partners at the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta, Baruch S. Blumberg Institute, Scripps Research Institute and Li Ka Shing Institute of Virology whose support has been monumental in our quest for an HBV cure. Abstract #3094: “Pharmacokinetic-Pharmacodynamic Modeling of Tenofovir Exalidex (TXL™) in HBV Subjects” p
Show less
Read more
Impact Snapshot
Event Time:
CTRV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTRV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTRV alerts
High impacting CONTRAVIR PHARMACEUTICALS INC news events
Weekly update
A roundup of the hottest topics